Jitoglim VOME 2/0.2/1000 Tablet (10 Tab)

Jitoglim VOME 2/0.2/1000 Tablet Overview:

Jitoglim VOME 2/0.2/1000 Tablet is an oral anti diabetic medication, which is used as a third-line treatment for type 2 diabetes mellitus (T2DM).

It is prescribed when lifestyle changes, such as diet, exercise, and previous treatment with one or two oral anti diabetic medications, fail to control blood sugar levels effectively. Type 2 diabetes can lead to serious complications, such as heart attack and stroke, as well as kidney damage, nerve damage, vision problems, slow wound healing, etc.

Jitoglim VOME Tablet plays an important role by enhancing the body's response to insulin or increasing the body's production of insulin, thereby reducing the risk of these potentially debilitating symptoms.

Composition:

Each film coated Bi-Layered tablet contains- Glimepiride: 2 mg, Voglibose: 0.2 mg, Metformin Hydrochloride (As Extended Release form): 1000 mg and Excipients q.s.

Colour: Quinoline Yellow

Uses and Benefits of Jitoglim VOME 2/0.2/1000 Tablet:

Jitoglim VOME 2/0.2/1000 Tablet is used for the treatment of Type II diabetes mellitus or non-insulin dependent diabetes mellitus (NIDDM).

How Jitoglim VOME 2/0.2/1000 Tablet Works:

Jitoglim VOME 2/0.2/1000 Tablet is a combination of three oral antidiabetic drugs: glimepiride, voglibose, and metformin. Together, they help improve glycemic control in type II diabetes mellitus patients.

Glimepiride, a sulfonylurea, lowers blood sugar by stimulating the pancreas to release more insulin. Voglibose is an alpha-glucosidase inhibitor that slows the digestion of complex carbohydrates in the small intestine and reduces the rapid rise in blood glucose after meals (postprandial hyperglycemia). Meanwhile, metformin, a biguanide, works by decreasing the liver's glucose production, slowing glucose absorption in the intestines, and enhancing the body's response to insulin.

Dosage of Jitoglim VOME 2/0.2/1000 Tablet:

• Usage Direction

Take Jitoglim VOME 2/0.2/1000 Tablet exactly as your doctor prescribes, and follow the recommended dosage and schedule. Jitoglim VOME 2/0.2/1000should be swallowed as a whole without crushing, chewing, or breaking it, and ideally at the same time each day. Do not stop or alter the dose of Jitoglim VOME 2/0.2/1000 Tablet without consulting your doctor, as this may prevent you from achieving the desired outcome. Regular monitoring of your blood and urine while taking Jitoglim VOME 2/0.2/1000 Tablet may improve your condition. Ask your doctor or pharmacist to explain any administration procedure you do not understand.

• Missed Dose

If you miss a dose of Jitoglim VOME 2/0.2/1000 Tablet, take it as soon as it is remembered. If it is time for your next dose of Jitoglim VOME 2/0.2/1000 Tablet, skip the missed dose and resume your regular schedule. Avoid taking two doses to compensate for a missed one.

• Overdose

If you accidentally take Jitoglim VOME 2/0.2/1000 Tablet more than your prescribed dose, it may lead to severe hypoglycemia. To manage hypoglycemia on an emergency basis, take fast-acting carbohydrates like sugar, fruit juice, honey, etc and seek medical advice immediately.

Contraindications of Jitoglim VOME 2/0.2/1000 Tablet:

Do not take Jitoglim VOME 2/0.2/1000 Tablet if you are allergic to glimepiride, other sulfonylureas, sulfonamides, metformin, voglibose, or any of its ingredients. This medication should also be avoided if you have Type 1 diabetes, insulin-dependent diabetes, diabetic ketoacidosis, diabetic pre-coma, lactic acidosis, severe kidney or liver dysfunction, acute alcohol intoxication, decompensated heart failure, respiratory failure, recent heart attack, severe infections or trauma, gastrointestinal obstruction, or a tendency for such conditions.

Precautions & Warnings of Jitoglim VOME 2/0.2/1000 Tablet:

Before starting Jitoglim VOME 2/0.2/1000 Tablet, inform your doctor if you are taking any hypoglycemic medications that could increase the risk of cardiovascular mortality. Consult your doctor if you have a history of lactic acidosis, cardiovascular collapse (shock), acute congestive heart failure, acute myocardial infarction, or any conditions linked to hypoxemia, as these have been associated with lactic acidosis.

Side Effects of Jitoglim VOME 2/0.2/1000 Tablet:

Jitoglim VOME 2/0.2/1000 Tablet may also cause some side effects, most of which do not require medical attention and typically go away as your body adapts to the medication. These may include nausea, vomiting, diarrhoea, abdominal pain, heartburn and loss of appetite, blood & lymphatic disorders, metallic taste, abdominal distention, increased flatus and intestinal obstruction. However, if these side effects persist, consult your doctor as soon as possible. Some of the side effects may also be serious and may need medical attention such as; hypoglycaemia, lactic acidosis, eye disorders, etc.

Safety Related Concerns of Jitoglim VOME 2/0.2/1000 Tablet:

• Pregnancy

If you are planning to become pregnant or if a pregnancy is discovered, it's important to consult with your doctor to determine whether it is safe for you to continue with Jitoglim VOME 2/0.2/1000 Tablet. Gestational diabetes, which occurs during pregnancy, carries an increased risk of birth defects. Therefore, your doctor may recommend switching to insulin therapy to better control blood sugar levels. It is essential to monitor blood glucose levels closely throughout pregnancy to minimize the risk of fetal malformations.

• Breastfeeding

Breastfeeding mothers are advised to avoid Jitoglim VOME 2/0.2/1000 Tablet as it may pass through breast milk and can cause side effects in breastfed babies. Therefore, it is important to consult your doctor before taking Jitoglim VOME 2/0.2/1000while breastfeeding.

• Alcohol

It is recommended to avoid drinking alcohol while taking Jitoglim VOME 2/0.2/1000 Tablet, as it can increase the risk of low blood sugar (hypoglycemia) and may also cause lactic acidosis.

• Food Interactions

Jitoglim VOME 2/0.2/1000 Tablet should be taken with or immediately before a meal, as advised by the doctor. Do not skip or delay meals after taking this medicine, as this can increase the risk of low blood sugar, particularly because glimepiride stimulates insulin release. Limit foods and drinks that are very high in sugar, as they can make blood sugar control more difficult. Maintain a balanced diet with appropriate portions of carbohydrates, vegetables, protein, and fibre as recommended for diabetes management.

• Drug Interactions

Jitoglim VOME 2/0.2/1000 Tablet may interact with other medicines and can sometimes change their effects on blood sugar. Medicines such as insulin and other antidiabetic drugs may further lower blood sugar. Beta-blockers may mask some warning signs of hypoglycaemia, while steroids and certain diuretics may increase blood sugar. Some medicines, including certain NSAIDs, ACE inhibitors, fibrates, salicylates and MAO inhibitors, may also affect blood glucose control.

• Using Machinery & Driving

If you experience side effects such as dizziness or blurred vision, you should avoid driving or operating machinery while taking Jitoglim VOME 2/0.2/1000 Tablet.

Storage Instructions:

Store in a cool, dry & dark place. Protect from light & moisture. Keep the medicine out of reach of children.

Dispose of expired or unneeded medications properly through local regulations or pharmacy take-back programs. Check expiration dates regularly and never use expired medication, as potency may decrease or safety may be compromised.

Helpful Tips:

• Take the tablet at the same time every day to help maintain consistent blood sugar control.
• Follow a balanced diabetic diet and regular exercise plan along with the medicine.
• Monitor your blood glucose levels regularly as advised by your healthcare professional.
• Stay adequately hydrated, particularly during hot weather, vomiting, or diarrhoea.
• Regularly monitor kidney function as advised, particularly during long-term treatment.
• Keep a quick source of sugar, such as glucose tablets, sugar, fruit juice, or regular non-diet soft drink, readily available for emergency use in case of symptoms of low blood sugar or hypoglycemia.
• Do not share your medicine with someone else having the same symptoms as you.

Related Blood Glucose Monitors:

To manage diabetes at home, discover our simple, reliable home-use Blood Glucose Monitoring systems with Test Strips. Check Out

Frequently Asked Questions (FAQs):

Q. Is Jitoglim VOME 2/0.2/1000 Tablet used for sugar treatment?

A: Yes, Jitoglim VOME 2/0.2/1000 Tablet is a combination oral anti-diabetic medication used to manage blood sugar levels by enhancing insulin sensitivity, thereby treating Type 2 diabetes mellitus. It is prescribed when diet, exercise, and one or two other anti-diabetic drugs do not provide sufficient control of blood sugar.

Q. Does Jitoglim VOME 2/0.2/1000 Tablet lead to hypoglycemia?

A: Jitoglim VOME 2/0.2/1000 Tablet is usually recommended for managing Type II diabetes mellitus. However, taking more than the prescribed dose or using it alongside other antidiabetic medications can lead to dangerously low blood sugar levels, a condition known as hypoglycemia.

Q. What is the difference between Glycomet GP 2 Tablet and Jitoglim VOME 2/0.2/1000 Tablet?

A: The primary difference between Glycomet GP 2 Tablet and Jitoglim VOME 2/0.2/1000 Tablet lies in their composition, both of which are used to treat Type II diabetes mellitus. Glycomet GP 2 Tablet combines Glimepiride and Metformin, while Jitoglim VOME 2/0.2/1000 Tablet contains Glimepiride, Voglibose and Metformin. It is essential to take only the medication prescribed by your doctor according to your physical condition and avoid self-medication.

Q. What happens if blood sugar drops too quickly?

A: When blood sugar levels drop too quickly, it can result in hypoglycemia. Symptoms may include shaking or trembling, dizziness, weakness, a rapid heart rate, sweating, and chills. In severe cases, it can cause confusion, seizures, or even coma, which can be life-threatening. To manage hypoglycemia on an emergency basis by consuming fast-acting carbohydrates such as glucose tablets, sugary products, or regular soda to restore blood sugar to normal levels.

Q. Is Jitoglim VOME 2/0.2/1000 Tablet an insulin?

A: No, Jitoglim VOME 2/0.2/1000 Tablet is not an insulin. While insulin is a hormone, Jitoglim VOME 2/0.2/1000 Tablet is a combination of three oral antidiabetic drugs: Glimepiride, Voglibose and Metformin. It is commonly prescribed to individuals with type 2 diabetes to help regulate blood sugar levels.

Q. Which food should avoid while taking Jitoglim VOME 2/0.2/1000 Tablet?

A: While using Jitoglim VOME 2/0.2/1000 Tablet, it is advisable to avoid foods and drinks high in natural or added sugars, such as fruit juice, soda, candy, desserts, white bread, rice, chips, sugary cereals, ice cream, and sweetened milk. Additionally, alcohol should be avoided during this treatment as it can lower blood sugar levels, increasing the risk of hypoglycemia, and may also raise the likelihood of developing lactic acidosis.

Q. Can Jitoglim VOME 2/0.2/1000 Tablet cause weight gain?

A: Yes, Jitoglim VOME 2/0.2/1000 Tablet may cause weight gain due to its ingredient Glimepiride, which belongs to the Sulfonylureas class of medications. Sulfonylureas work by stimulating the pancreas to produce more insulin, which helps lower blood sugar levels. However, insulin also promotes fat storage in the body. As a result, increased insulin levels can lead to the storage of more fat, potentially causing weight gain. If you're concerned about weight gain while taking Jitoglim VOME 2/0.2/1000 Tablet, it is important to discuss it with your healthcare provider. They can adjust your treatment plan to help manage both your blood sugar and weight.

References:

1. Fixed Dose Combinations Approved By DCG (I) From 1st January 2020 to 31st October 2020. Accessed on: 2nd September 2026. Click Here

2. Diabetes UK. About Diabetes. Accessed on: 2nd September 2026. Click Here

3. Abridged Prescribing Information. Metformin Hydrochloride (SR), Glimepiride, & Voglibose Tablets. Amaryl MV 1mg. Amaryl MV 2mg. Last Revised on: March 2021. Accessed on: 2nd September 2026. Click Here

4. Glimitab MV 1/2. Accessed on: 2nd September 2026. Click Here